We also analyzed IFNγ-producing T cells in the spleen and found that the percentage of IFNγ-producing CD4 T cells in anti-ERMAP mAb-treated AD mice was significantly higher than that in control mAb-treated mice (Fig. 5E, F). The gene discussed is ERMAP; the disease is Alzheimer disease.